BeamMed
Ultrasound Technology for Measuring Bone Density
Company Overview
Snapshot
Founded in April 2004, BeamMed operates with 11–50 employees. The company has raised $4 million across one funding round. BeamMed develops, manufactures, and markets bone-related screening, diagnostic, and monitoring solutions, leveraging patented Omnipath axial transmission technology.
Business overview
BeamMed develops, manufactures, and markets advanced bone-related screening, diagnostic, and monitoring solutions. The company's core technology utilizes patented Omnipath axial transmission ultrasound to produce devices that enable physicians to provide early assessment, diagnosis, and monitoring of osteoporosis, as well as to assess bone growth. BeamMed serves the healthcare industry, including clinics, hospitals, and home care providers, with products like the Sunlight Omnisense 9000 and MiniOmni Quantitative Ultrasound devices, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices, Diagnostics Devices, and Medical Monitors.
Strategic signal
In May 2020, BeamMed rolled out a significant upgrade, "1-Cycle Express," for its MiniOmni Portable Bone Density Scanner. This enhancement signals the company's ongoing commitment to product innovation and improving the efficiency of its diagnostic tools, which is crucial for maintaining competitiveness and expanding market adoption in the medical device sector.
Company Intelligence Q&A
- What is BeamMed's core technology?
- BeamMed's core technology is the patented Omnipath axial transmission technology, a quantitative ultrasound method used for accurate and safe bone-related screening, diagnosis, and monitoring.
- What products does BeamMed offer?
- BeamMed offers products such as the Sunlight Omnisense 8000, Sunlight Omnisense 9000, and Sunlight MiniOmni, which are quantitative ultrasound devices for assessing bone density.
- When was BeamMed founded?
- BeamMed was founded in April 2004.
- What was a key product update for BeamMed's MiniOmni device?
- In May 2020, BeamMed rolled out a major and faster upgrade called "1-Cycle Express" for its MiniOmni Portable Bone Density Scanner.
- What is the total disclosed funding BeamMed has raised?
- BeamMed has raised a total of $4 million across one funding round in May 2010 from D.N.A Biomedical Solutions Ltd.